Evidence map›Paper›PMID 38223563›Full record

ArticleInfection and drug resistance2024

Insights into the in-vitro Susceptibility and Drug-Drug Interaction Profiles Against Drug-Resistant and Susceptible

Aynias Seid, Yilak Girma, Eseye Dereb, Meseret Kassa, Semira Nureddin, Ayenesh Abebe, Nega Berhane

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Aynias SeidDepartment of Biology, College of Natural and Computational Science, Debre-Tabor University, Debre-Tabor, Ethiopia.ORCID 0000-0002-1304-7129
Yilak GirmaTB Culture Laboratory, University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.
Eseye DerebTB Culture Laboratory, University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.
Meseret KassaTB Culture Laboratory, University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.
Semira NureddinDepartment of Biology, College of Natural and Computational Science, Woldia University, Woldia, Ethiopia.
Ayenesh AbebeTB Culture Laboratory, University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.
Nega BerhaneDepartment of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia.ORCID 0000-0003-1492-2746
University of Gondar · ETDebre Tabor University · ETWoldia University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In Ethiopia, tuberculosis (TB) is a major public health problem. The aim of the study was to determine the in vitro susceptibility level of drugs and drug interaction profiles against drug-resistant and susceptible Results: Among 32 clinical isolates, a total of 14 (43.8%) RIF, 20 (62.5%) INH, 2 (6.3%) EMB-related resistant and 14 (43.8%) MDR isolates were identified. Five of RIF-resistant isolates (55.6%) carrying Conclusion: The study highlights that isolates with

Indexed as

drug combinationdrug interactionMICmutationssynergism

Identifiers

PMID38223563
PMCPMC10788062
OpenAlexW4390701772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.